Trade Summary

Yesterday, MAHON PAUL A, serving as EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $547.07 per share, for a total transaction value of $4,540,642.41. Following this transaction, MAHON PAUL A now holds 45,172 shares of UTHR.

This sale represents a 15.52% decrease in MAHON PAUL A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 at 5:30 PM ET, meaning the disclosure happened on the same day as the trade.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.